SentiSearch Inc. Stock Analysis SSRC
SentiSearch, Inc. is a development stage company. The company is headquartered in New York City, New York and currently employs 1 full-time employees. The company went IPO on 2006-12-01. The firm holds the rights to the olfaction intellectual property assets and certain applications titled Nucleic Acids and Proteins of Insect OR83b odorant receptor genes. The olfaction intellectual property assets can be used in Odorant receptors; cloning of vertebrate pheromone receptors, and genes encoding insect odorant receptors and their uses. The firm's gene modification process applications focus on the isolation of genes that are ubiquitous among insects. In collaboration with Bayer CropScience, the Company is developing solutions to control and eradicate insect-borne diseases, such as malaria and dengue fever.
Read More SentiSearch Inc (SSRC) Chart
Key Statistics of SentiSearch Inc (SSRC)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
-P/E Ratio (TTM)
-52 Week Range
Market Cap
16.80Avg. Volume
62.50Dividend Yield
-Financial Metrics & Statements of SentiSearch Inc (SSRC)
FAQ's for SentiSearch Inc (SSRC)
- According to Musaffa’s Shariah screening methodology, SentiSearch Inc (SSRC) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.